New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 20, 2012
12:43 EDTMNTAMomenta Pharma petition for rehearing denied by Court of Appeals
Momenta Pharmaceuticals announced that the United States Court of Appeals for the Federal Circuit denied its request for a rehearing en banc to reconsider its three-judge panel opinion in the case of Momenta Pharmaceuticals vs. Amphastar Pharmaceuticals, Inc. The request for all active judges of the court to reconsider a panel decision, known as rehearing en banc, is only granted upon a majority vote. "We will continue to pursue our appellate options and we plan to file a petition for certiorari, asking the Supreme Court to review this case," said Craig Wheeler, president and CEO of Momenta.
News For MNTA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 23, 2015
06:32 EDTMNTAMomenta enters $75M At-The-Market equity sales agreement with Stifel
Subscribe for More Information
February 18, 2015
07:56 EDTMNTAMomenta price target lowered to $15 from $18 at UBS
Subscribe for More Information
February 17, 2015
08:10 EDTMNTAMomenta reports Q4 EPS (31c), consensus (26c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use